AMYRIS INC (AMRS) Stock Price, Forecast & Analysis

USA Nasdaq NASDAQ:AMRS • US03236M2008

0.05 USD
-0.01 (-21.87%)
At close: Aug 18, 2023
0.052 USD
+0 (+4%)
After Hours: 8/18/2023, 8:19:54 PM

AMRS Key Statistics, Chart & Performance

Key Statistics
Market Cap18.47M
Revenue(TTM)268.22M
Net Income(TTM)-614.55M
Shares369.39M
Float248.23M
52 Week High4.86
52 Week Low0.05
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.67
PEN/A
Fwd PEN/A
Earnings (Next)11-06
IPO2010-09-28
Sector
GICS SectorMaterials
GICS IndustryChemicals
GICS IndustryGroupMaterials
GICS SubIndustrySpecialty Chemicals
AMRS short term performance overview.The bars show the price performance of AMRS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

AMRS long term performance overview.The bars show the price performance of AMRS in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of AMRS is 0.05 USD. In the past month the price decreased by -94.62%. In the past year, price decreased by -98.26%.

AMYRIS INC / AMRS Daily stock chart

AMRS Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

AMRS Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to AMRS. AMRS may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AMRS Financial Highlights

Over the last trailing twelve months AMRS reported a non-GAAP Earnings per Share(EPS) of -1.67. The EPS decreased by -595.83% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%2.94%
Sales Q2Q%-2.82%
EPS 1Y (TTM)-595.83%
Revenue 1Y (TTM)-32.87%

AMRS Forecast & Estimates

14 analysts have analysed AMRS and the average price target is 1.74 USD. This implies a price increase of 3384.94% is expected in the next year compared to the current price of 0.05.

For the next year, analysts expect an EPS growth of 67.21% and a revenue growth 76.61% for AMRS


Analysts
Analysts72.86
Price Target1.74 (3380%)
EPS Next Y67.21%
Revenue Next Year76.61%

AMRS Ownership

Ownership
Inst Owners0%
Ins Owners4.57%
Short Float %N/A
Short RatioN/A

AMRS Competitors/Peers

The largest stocks on the US markets in the "Specialty Chemicals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
SHW SHERWIN-WILLIAMS CO/THE29.7389.731B
ECL ECOLAB INC33.9982.233B
PPG PPG INDUSTRIES INC15.6128.389B
DD DUPONT DE NEMOURS INC20.9819.579B
ALB ALBEMARLE CORP59.5319.229B
IFF INTL FLAVORS & FRAGRANCES16.619.161B
RPM RPM INTERNATIONAL INC19.3114.994B
SOLS SOLSTICE ADV MATERIALS INC21.710.284B
EMN EASTMAN CHEMICAL CO13.098.832B
ESI ELEMENT SOLUTIONS INC17.337.245B

About AMRS

Company Profile

AMRS logo image Amyris, Inc. engages in the provision of bioscience solutions. The company is headquartered in Emeryville, California and currently employs 1,598 full-time employees. The company went IPO on 2010-09-28. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Company’s sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F), Nutrition, Food & Beverage, and Clean Beauty & Personal Care end markets. The ingredients and consumer products it produces by its Lab-to-Market technology platform. The firm leverages machine learning, robotics, and artificial intelligence, which enables its technology platform to rapidly bring new market at commercial scale. The Lab-to-Market technology platform utilizes optimized and automated molecular biology, analytical, and process development tools combined with machine learning algorithms and statistical models to transform the way microbes metabolize sugars.

Company Info

AMYRIS INC

5885 Hollis St Ste 100

Emeryville CALIFORNIA 94608 US

CEO: John G. Melo

Employees: 1598

AMRS Company Website

Phone: 15104500761.0

AMYRIS INC / AMRS FAQ

What does AMRS do?

Amyris, Inc. engages in the provision of bioscience solutions. The company is headquartered in Emeryville, California and currently employs 1,598 full-time employees. The company went IPO on 2010-09-28. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Company’s sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F), Nutrition, Food & Beverage, and Clean Beauty & Personal Care end markets. The ingredients and consumer products it produces by its Lab-to-Market technology platform. The firm leverages machine learning, robotics, and artificial intelligence, which enables its technology platform to rapidly bring new market at commercial scale. The Lab-to-Market technology platform utilizes optimized and automated molecular biology, analytical, and process development tools combined with machine learning algorithms and statistical models to transform the way microbes metabolize sugars.


What is the stock price of AMYRIS INC today?

The current stock price of AMRS is 0.05 USD. The price decreased by -21.87% in the last trading session.


Does AMYRIS INC pay dividends?

AMRS does not pay a dividend.


What is the ChartMill technical and fundamental rating of AMRS stock?

AMRS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


What is the GICS sector and industry of AMRS stock?

AMYRIS INC (AMRS) operates in the Materials sector and the Chemicals industry.


How is the valuation of AMYRIS INC (AMRS) based on its PE ratio?

AMYRIS INC (AMRS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.67).


Should I buy AMRS stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AMRS.